ArticleCancer immunology, immunotherapy : CII2019

A VEGFR2-MICA bispecific antibody activates tumor-infiltrating lymphocytes and exhibits potent anti-tumor efficacy in mice.

Yao Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.